BioVaxys Technology Corp.

C$0.07As of Sun 8 Nov 2026, 12:00 UTC
CSE:BIOVHealthcare
Country Canada
PE (Fwd) •••
TSR 6Y CAGR (49.34%)
Div yield —
ROE —
Biotechnology
Beta (5Y) 1.63
PE TTM —
TSR TTM (74.55%)
Mkt cap C$3.087M
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.0815
16.44%
(88.73%)
Hold 8|2|4|1|4
4Q25
1Q26
2Q26
3Q26
Earnings per share$
—
—
—
—
21.29%
18.79%
11.86%
7.10%
Revenue$M
0.198
0.204
0.198
0.199
2.02%
5.75%
1.60%
4.41%
Peers (US$2.185M)
Cap (US$)
PE
2.312M
—
Capital
TTM
5Y
10Y
Leveragex
0.483
0.267
0.199
EBIT/Intx
3.292
0.181
0.176
Own earn%
(46.70)
(168.83)
(130.09)
Sh yield%
15.21
20.87
23.41
Owners
Insiders/Inst%
8.38
59.43
Short interest%
4.18
SBC / revenue%
4.49
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
5
Op margin range%
12–20
$1 testx
0.2
Incr. ROIC%
8